Concepedia

Melanie Sticker-Jantscheff

MS

4

Publications

221

Citations

4

H-Index

2006

Active since

Affiliations

Novartis (Switzerland)(Current)

Novartis Institutes for BioMedical Research

Melanie Sticker-Jantscheff is an author at Novartis (Switzerland) specializing in medicine, cell development, and developmental biology.

Top concepts

Publications per year

2006–2015

4

Publications

4

Ribosomal Protein <i>S6</i> Gene Haploinsufficiency Is Associated with Activation of a p53-Dependent Checkpoint during Gastrulation

Linda Panić, Sanda Tamarut, Melanie Sticker-Jantscheff et al. · Molecular and Cellular Biology · 2006 · 132 citations · Full text

, , +15

Anti-Angiogenic/Vascular Effects of the mTOR Inhibitor Everolimus Are Not Detectable by FDG/FLT-PET

Michael Honer, Thomas Ebenhan, Peter R. Allegrini et al. · Translational Oncology · 2010 · 33 citations · Full text

, , +19

Tumour T1 changes in vivo are highly predictive of response to chemotherapy and reflect the number of viable tumour cells – a preclinical MR study in mice

Claudia Weidensteiner, Peter R. Allegrini, Melanie Sticker-Jantscheff et al. · BMC Cancer · 2014 · 32 citations · Full text

S6K1 controls pancreatic β cell size independently of intrauterine growth restriction

Sung Hee Um, Melanie Sticker-Jantscheff, Gia Cac Chau et al. · Journal of Clinical Investigation · 2015 · 24 citations · Full text

, , +21

Rows per page

1–4 of 4